Literature DB >> 28026909

Plasma D-dimer levels and ischaemic lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke.

Y Gon1, M Sakaguchi1, J Takasugi1, T Kawano1, H Kanki1, A Watanabe1, N Oyama1, Y Terasaki1, T Sasaki1, H Mochizuki1.   

Abstract

BACKGROUND AND
PURPOSE: Cancer patients with cryptogenic stroke often have high plasma D-dimer levels and lesions in multiple vascular regions. Hence, if patients with cryptogenic stroke display such characteristics, occult cancer could be predicted. This study aimed to investigate the clinical characteristics of cryptogenic stroke as the first manifestation of occult cancer and to determine whether plasma D-dimer levels and lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke.
METHODS: Between January 2006 and October 2015, data on 1225 patients with acute ischaemic stroke were extracted from the stroke database of Osaka University Hospital. Among them, 184 patients were classified as having cryptogenic stroke, and 120 patients without a diagnosis of cancer at stroke onset were identified. Clinical variables were analyzed between cryptogenic stroke patients with and without occult cancer.
RESULTS: Among 120 cryptogenic stroke patients without a diagnosis of cancer, 12 patients had occult cancer. The body mass index, hemoglobin levels and albumin levels were lower; plasma D-dimer and high-sensitivity C-reactive protein levels were higher; and lesions in multiple vascular regions were more common in patients with than in those without occult cancer. Multiple logistic regression analysis revealed that plasma D-dimer levels (odds ratio, 3.48; 95% confidence interval, 1.68-8.33; P = 0.002) and lesions in multiple vascular regions (odds ratio, 7.40; 95% confidence interval, 1.70-39.45; P = 0.01) independently predicted occult cancer.
CONCLUSIONS: High plasma D-dimer levels and lesions in multiple vascular regions can be used to predict occult cancer in patients with cryptogenic stroke.
© 2016 EAN.

Entities:  

Keywords:  D-dimer; cryptogenic stroke; lesions in multiple vascular regions; occult cancer

Mesh:

Substances:

Year:  2016        PMID: 28026909     DOI: 10.1111/ene.13234

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  15 in total

1.  Occult cancer diagnosed following acute ischemic stroke.

Authors:  Bastien Rioux; Mark R Keezer; Laura C Gioia
Journal:  CMAJ       Date:  2020-09-08       Impact factor: 8.262

2.  Ovarian Cancer Presenting as Cryptogenic Stroke from Patent Foramen Ovale.

Authors:  Bindu R Potugari; Priyanka Priyanka; Sarah D Komanapalli; Richard J Mercier
Journal:  Clin Med Res       Date:  2019-07-19

3.  Cancer-Related Ischemic Stroke Has a Distinct Blood mRNA Expression Profile.

Authors:  Babak B Navi; Ryna Mathias; Carla P Sherman; Julia Wolfe; Hooman Kamel; Scott T Tagawa; Ashish Saxena; Allyson J Ocean; Costantino Iadecola; Lisa M DeAngelis; Mitchell S V Elkind; Heather Hull; Glen C Jickling; Frank R Sharp; Bradley P Ander; Boryana Stamova
Journal:  Stroke       Date:  2019-09-12       Impact factor: 7.914

4.  Adherence to Guideline-Recommended Cancer Screening in Stroke Survivors: A Nationwide Analysis.

Authors:  Marialaura Simonetto; Stephanie Rutrick; Natalie M LeMoss; Kelsey N Lansdale; Scott T Tagawa; Hooman Kamel; Neal Parikh; Babak B Navi
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-01-13       Impact factor: 2.136

5.  Clinical characteristics and tumor markers in ischemic stroke patients with active cancer.

Authors:  Tomohisa Nezu; Naohisa Hosomi; Hiroyuki Naito; Shiro Aoki; Tsuyoshi Torii; Takashi Kurashige; Tomohito Sugiura; Daisuke Kuzume; Yuko Morimoto; Takeshi Yoshida; Yoshiki Yagita; Naoki Oyama; Yuji Shiga; Naoto Kinoshita; Teppei Kamimura; Hiroki Ueno; Tomohiko Ohshita; Hirofumi Maruyama
Journal:  Intern Emerg Med       Date:  2021-10-01       Impact factor: 3.397

6.  Arteriovenous thrombotic events in a patient with advanced lung cancer following bevacizumab plus chemotherapy: A case report.

Authors:  Ying Kong; Xiao-Cheng Xu; Liang Hong
Journal:  World J Clin Cases       Date:  2022-07-06       Impact factor: 1.534

Review 7.  Cancer and Embolic Stroke of Undetermined Source.

Authors:  Babak B Navi; Scott E Kasner; Mitchell S V Elkind; Mary Cushman; Oh Young Bang; Lisa M DeAngelis
Journal:  Stroke       Date:  2021-01-28       Impact factor: 7.914

8.  Validation of an algorithm that determines stroke diagnostic code accuracy in a Japanese hospital-based cancer registry using electronic medical records.

Authors:  Yasufumi Gon; Daijiro Kabata; Keichi Yamamoto; Ayumi Shintani; Kenichi Todo; Hideki Mochizuki; Manabu Sakaguchi
Journal:  BMC Med Inform Decis Mak       Date:  2017-12-04       Impact factor: 2.796

9.  Potential Pathogenesis and Biomarkers of Kidney Cancer-Related Stroke.

Authors:  Haihong Jiang; Chao Qin; Daobin Cheng; Qiuhong Lu; Gelun Huang; Dacheng Wang; Hong Yang; Zhijian Liang
Journal:  Med Sci Monit       Date:  2017-05-15

10.  Recurrent stroke in a patient of lung cancer without pulmonary mass: A case report.

Authors:  Lisha Wang; Yan Xu; Minghui Tuo; Lei Zhang; Hong Zhang; Jing Wang
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.